Tempus AI, Inc. (TEM) स्टॉक विश्लेषण

कंपनी का अवलोकन

Tempus AI, Inc. operates as a prominent healthcare technology entity within the United States, providing a comprehensive closed-loop platform that integrates clinician desktops with laboratory diagnostic capabilities and a vast repository of multimodal data. The company functions within the Healthcare sector, specifically specializing in Health Information Services, which implies a focus on digitizing and managing critical medical data to enhance clinical decision-making and operational efficiency. Tempus AI, Inc. demonstrates significant scale with a market capitalization of $8.52B, an annual revenue of $1.27B, and an employee base of 3800 individuals. These substantial valuation and revenue figures indicate that the market assigns a premium to the company's proprietary data infrastructure and full-stack integration capabilities, positioning it as a major player in the evolving landscape of digital health infrastructure.

वित्तीय स्वास्थ्य

The company reported a revenue of $1.27B (TTM), yet it recorded a net income of $-245,028,000 and an EBITDA of $-171,512,992, revealing a substantial gap between top-line growth and bottom-line profitability that suggests high operational expenditures or significant investment costs are consuming earnings. The free cash flow stands at $-112,498,872, which indicates that the company is currently burning cash rather than generating surplus liquidity, a situation common for high-growth firms but one that limits immediate financial flexibility for dividends or buybacks. Analysis of the margins shows a Gross Margin of 62.7%, which is healthy for a software and data-driven business, while the Operating Margin sits at -16.7% and the Profit Margin at -19.3%, highlighting that while revenue generation is efficient, overhead costs are disproportionately high relative to net earnings. The balance sheet presents a complex picture with $755.00M in cash held against $1.33B in total debt, resulting in a Debt to Equity ratio of 270.11, which suggests a highly leveraged position where liabilities significantly exceed equity capitalization. However, the Current Ratio of 3.13 indicates strong short-term liquidity, meaning the company possesses ample current assets to cover its short-term obligations despite the heavy debt load. Furthermore, the Return on Equity is -89.5% and the Return on Assets is -9.7%, metrics that reveal that management has not yet generated positive returns on shareholder capital or total assets, reflecting the current stage of investment and expansion rather than mature profitability.

मूल्यांकन आकलन

The valuation metrics present a challenging profile with a Trailing P/E Ratio (TTM) listed as N/A due to negative earnings, while the Forward P/E is -760.61, a figure that implies the market is pricing in a significant turnaround or expects earnings to become positive within the forecast period, though such a high negative ratio typically signals high risk or deep losses. The Price to Book ratio stands at 17.22, indicating that the stock trades at a massive premium over its book value, suggesting investors are willing to pay significantly more for the company's assets than their accounting value, likely betting on future intangible growth. Alternative valuation measures include a Price to Sales ratio of 6.70 and an EV/EBITDA of -52.85, which suggest that the market is valuing the company primarily on its revenue generation and market potential rather than current cash flows or earnings power. The stock has traded between a 52-Week High of $104.32 and a 52-Week Low of $36.22; without a specific current price, the range defines the volatility envelope within which the asset has moved over the past year. The Beta is listed as N/A, preventing a direct comparison of price volatility relative to the broader market, though the wide spread between the high and low suggests inherent high volatility typical of biotech and health-tech stocks.

Growth & Income

Tempus AI, Inc. is experiencing explosive expansion with a Revenue Growth (YoY) of 83.0%, while Earnings Growth (YoY) is N/A due to the company's persistent losses, implying that revenue expansion is currently the primary driver of business development rather than profit acceleration. Since the company does not pay a dividend, indicated by a Dividend Yield of N/A and a Payout Ratio of 0.0%, it follows a strategy of reinvesting all available earnings back into research, development, and platform expansion rather than distributing income to shareholders. The absence of a dividend payout ratio confirms that the company prioritizes capital expenditure and scaling operations over providing immediate income returns to investors. Overall, the growth and income profile characterizes Tempus AI, Inc. as a high-risk, high-potential growth asset that offers no current income stream but relies entirely on future profitability to validate its current market valuation.